T
he Gram-negative bacterium Haemophilus ducreyi is the causative agent of the sexually transmitted genital ulcer disease chancroid (reviewed in references 1 to 3). Chancroidal lesions are soft, purulent, and painful ulcers that bleed easily upon contact (3, 4) . In both natural and experimental chancroid, H. ducreyi is found mostly in the dermis, colocalizing with neutrophils and fibrin, but it can also be found in the extracellular space of the epidermis (5, 6) . Survival of H. ducreyi in this hostile environment is thought to be dependent on many factors, including resistance to phagocytosis and to the bactericidal activity of normal human serum (NHS). One outer membrane protein (OMP) of H. ducreyi, the ducreyi serum resistance A (DsrA) protein, has been shown to be involved in serum resistance by preventing binding of naturally occurring IgM at its surface (7, 8) . DsrA is required for full virulence in human experimental H. ducreyi infection (9) .
DsrA belongs to the family of trimeric autotransporter adhesin (TAA), multifunctional outer membrane proteins involved in adhesion and serum resistance (10) . Structurally, TAA proteins contain three domains: an N-terminal signal peptide, a passenger domain, and a C-terminal translocator region (11) . The highly conserved translocator domain of TAA, which serves as the criterion for inclusion of proteins in this family, anchors TAA in the outer membrane. The passenger domain of TAA is involved in its different functions. As the name implies, TAA proteins are expressed as trimers at the surface of bacterial cells, and trimerization of the passenger domain is required for structural stability, adhesive activity, and virulence (12, 13) . The prototypical protein for this group of proteins, YadA from Yersinia enterocolitica, is lollipop shaped, with the head of YadA forming the lollipop portion. In YadA, both fibronectin (Fn) and collagen binding domains are found in the head section (14) . DsrA does not bind collagen but interacts with Fn and vitronectin (Vn) (15, 16) . Fn and Vn binding are mediated by amino acids in the C-terminal region of the DsrA passenger domain (17) .
There are two clonal populations of H. ducreyi strains, termed class I and class II (18) (19) (20) (21) , based on variant outer membrane determinants, including DsrA (18) (19) (20) (21) . Each class of H. ducreyi strains expresses a different DsrA protein, termed DsrA I and DsrA II for class I and class II strains, respectively (18) . Despite low homology in their passenger domains, the two classes of DsrA proteins possess the same functions: both DsrA I and DsrA II confer serum resistance and Fn and Vn binding (16) . Fibrinogen (Fg) is a large serum glycoprotein involved in coagulation, wound healing, neoplasia, angiogenesis, and the inflammatory response (22, 23) . Fg interacts with the extracellular matrix (ECM) and cells. The 340-kDa Fg molecule is composed of three nonidentical peptide chains, termed ␣, ␤, and ␥, pairs of which are joined together by disulfide bonds (23) . Fg binding proteins of Gram-positive bacteria have been well characterized and have been shown to be involved in pathogenesis (24, 25) ; however, there is less evidence about the presence of Fg binding proteins in Gram-negative bacteria and their role in disease. H. ducreyi was first shown to interact with Fg in a latex bead agglutination assay, where all 21 isolates tested bound Fg (26) . In 2009, a lipoprotein termed FgbA (HD0192) was shown to bind digoxigenin (DIG)-Fg in ligand blotting of denatured proteins from prototypical class I H. ducreyi strain 35000HP. FgbA was shown to be involved in the pathogenesis of experimental chancroid (27) . Because H. ducreyi colocalizes with fibrin in both natural and experimental chancroid, we sought to identify the cell surface receptor of H. ducreyi that interacts with the precursor of fibrin, Fg. In two different binding assays using intact bacterial cells, only H. ducreyi lacking expression of dsrA had significantly reduced amounts of cell-associated Fg compared to the wild-type parental strain. Furthermore, complementation of an isogenic dsrA mutant restored Fg binding and conferred binding to a Haemophilus influenzae strain incapable of binding Fg. A 13-amino-acid sequence in the translocator domain of DsrA was shown to be involved in the interaction of Fg at the surface of H. ducreyi cells. Our findings indicate that Fg interacts specifically and in a dose-dependent manner with DsrA at the surface of viable H. ducreyi cells.
MATERIALS AND METHODS
Bacterial strains and culture conditions. H. ducreyi strains (Table 1) were routinely cultured and passaged on chocolate agar plates (CAP) containing GC medium base (Difco, Detroit, MI) and 1% bovine hemoglobin (Becton, Dickinson, Sparks, MD), supplemented with 5% FetalPlex (Gemini Bio-Products, West Sacramento, CA) and 1ϫ GGC (0.1% glucose, 0.001% glutamine, 0.026% cysteine) (28) at 34.5°C in 5% CO 2 . H. ducreyi strains were also cultured on heme plates containing GC medium base and 50 g/ml heme (H5533; Sigma-Aldrich, St. Louis, MO) and supplemented with 1ϫ GGC. H. influenzae strains expressing different plasmids (Table 1) were cultured on CAP supplemented with 1% IsoVitalex (BD, Franklin Lakes, NJ). Streptomycin (100 g/ml) was added to the growth medium when appropriate.
Construction of in-frame dsrA I deletion mutants. To complement a panel of truncated DsrA proteins already constructed (17) , two more in-frame dsrA I deletion mutants were created in the N-terminal region of the passenger domain of DsrA I . Two forward primers, DsrAxH and DsrAxI (Table 2) , were each used separately in combination with primer DsrAxE (17) and pUNCH1260 as the template to generate two separate PCR products using the following conditions: 95°C for 5 min for 1 cycle, followed by 30 cycles at 95°C for 1 min, 52°C for 1 min, and 72°C for 1 min, with a final polishing step at 72°C for 5 min. The products from these PCRs (DsrAxH-E and DsrAxI-E) were digested overnight with XmaI, cleaned, and ligated for 30 min at room temperature with XmaI-treated pUNCH1424, as previously described (17) , to form pUNCH2105 and pUNCH2106, respectively.
Smaller deletions were also made in the passenger (pUNCH1764) and translocator (pUNCH1706 and pUNCH1707) domains of DsrA. For each of these three constructs, overlap extension PCR with Pfx polymerase (Grand Island, NY) was used to generate three separate PCR products. Two separate PCRs were performed to generate the 5= and 3= portions of the constructs, using primers 1 and 2 and primers 3 and 4 (Table 2) , respectively, with the appropriate primers 2 and 3 used for each construct. pUNCH1260 was used as the DNA template. The conditions for the first two PCRs were as follows: for the 5= region, 1 cycle at 95°C for 2 min, followed by 30 cycles of denaturation (95°C, 15 s), annealing (43°C for pUNCH1706, 43°C for pUNCH1707, and 45°C for pUNCH1764) for 30 s, and extension (68°C, 1 min), with a final 1-cycle polishing step at 68°C for 5 min; for the 3= region, the conditions for PCRs were identical to those for the 5= region, except that the annealing step was carried out at 41°C for pUNCH1707. The third PCR was use to make the final construct containing the 5= and 3= regions next to the deletion. For this reaction, primers 1 and 4 were used with PCR products obtained with the first and second PCRs as templates. The conditions for this last PCR are identical to those described above, except that the annealing step for all of the constructs was performed at 45°C, and the extension step lasted 90 s instead of 60 s. All PCR products were subsequently ligated and electroporated into the single isogenic dsrA mutant FX517 (7). Clones expressing recombinant proteins of the expected size were selected based on protein expression, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie blue staining. The DNA sequence of the chosen clones was confirmed by sequencing at the University of North Carolina (UNC) sequencing facility. Expression of truncated DsrA proteins at the surface of H. ducreyi cells was verified with a rabbit polyclonal antibody (Ab) developed to the passenger domain of DsrA I (rNT-DsrA I ) in a whole-cell binding assay (17) .
SDS-PAGE and Western and ligand blotting. Total cellular proteins prepared from strains of H. ducreyi were subjected to SDS-PAGE under reducing conditions (except for the experiment shown in Fig. 2 ) at 150 V using a mini-Protean II system (Bio-Rad, Hercules, CA). Gels were transferred onto nitrocellulose membranes for 2 h at 200 mA and blocked overnight in 0.5% Tween 20 in phosphate-buffered saline (PBS) (blocking solution). Membranes were treated in either of two ways: ligand blotting with DIG-labeled Fg (for the experiment shown in Fig. 2 only) or Western blotting. For ligand blotting, 100 g of Fg (depleted of plasminogen, von Willebrand factor, and Fn) (Enzyme Research Laboratories, South Bend, IN) was labeled with DIG (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions. The membranes were thereafter incubated with DIG-Fg (1:10,000) in blocking solution for 1 h at room temperature. After three washes with 0.05% Tween 20 in PBS (wash buffer), the membranes were incubated with an anti-DIG secondary Ab (Roche Diagnostics, Mannheim, Germany) for 1 h at room temperature with mixing. After three more washes, the membranes were developed by chemiluminescence using the substrate LumiPhos WB (Thermo Fisher Scientific, Pittsburgh, PA). For Western blotting, membranes were incubated with either anti-Fg (1:10,000; Sigma-Aldrich, St. Louis, MO) in the Fg binding assay (described below), recombinant full-length DsrA I (rFLDsrA I ) (18) , or a polyclonal rabbit Ab to recombinant DltA (29) at a dilution of 1:25,000 for 30 min at room temperature. After three washes, the membranes were incubated with an anti-goat or anti-rabbit alkaline phosphatase-conjugated secondary Ab (Sigma-Aldrich, St. Louis, MO) for 30 min at room temperature and developed using chemiluminescence.
Fg binding assay. The Fg binding assay was carried out exactly as described for the Fn binding assay (16) , using suspensions of intact, viable H. ducreyi bacteria and purified Fg; however, in this instance, cell-associated Fg was measured both by Western blotting and flow cytometry. Briefly, suspensions (1 ml at an optical density at 600 nm [OD 600 ] of 0.5; approximately 2.5 ϫ 10 8 CFU/ml) of bacteria grown on CAP or heme plates (15 to 16 h) were prepared in GC broth (GCB) and incubated with amounts of Fg indicated in Fig. 1 or the legends of the other figures for 30 min at 34.5°C (5% CO 2 and humidified atmosphere), with mixing every 10 min. Bacterial cells were thereafter washed three times for 30 min with GCB. The resulting pellet was transferred to a new microcentrifuge tube and washed a fourth time. After the whole-cell binding assay, we assessed Fg bound to the surface of H. ducreyi using two methods. Bacteria pellets were suspended in Laemmli sample buffer with ␤-mercaptoethanol, and a 3-l aliquot was subjected to SDS-PAGE (12%) and Western blotting with anti-Fg as described above. We also used flow cytometry to assess H. ducreyi-associated Fg. Bacterial suspensions were incubated with fluorescein isothiocyanate (FITC)-Fg (labeled according to the manufacturer's instructions) (FluoReporter FITC Protein Labeling Kit; Life Technologies, Grand Island, NY) as described above and analyzed using an Accuri C6 Flow Cytometer (BD Biosciences, San Jose, CA). A total of 100,000 events were recorded, and a threshold of 10,000 was used. FCS Flow Cytometry data analysis (De Novo Software, Los Angeles, CA) was used to create the histograms from data obtained with the C6 cytometer.
For competition assays, Fg was first labeled with DIG (Roche Diagnostics GmbH, Mannheim, Germany). Unlabeled Fg was then incubated with suspensions of intact, viable H. ducreyi cell suspensions for 30 min prior to addition of DIG-Fg. Cell-associated Fg was measured as described above. Previous data from the unlabeled Fn binding assay as well as other unpublished data from our laboratory indicate that the viability of H. ducreyi cells is conserved after four washes of 30 min and that H. ducreyi can survive at least 6 h at room temperature (data not shown). Therefore, bacterial cells analyzed by flow cytometry were viable at the time of analysis.
Serum susceptibility. H. ducreyi resistance to 50% NHS was determined as previously described (18) . Results are expressed as percent survival of H. ducreyi bacteria in fresh NHS compared to survival in heated NHS (⌬NHS) [(number of CFU in fresh NHS/number of CFU in ⌬NHS) ϫ 100].
Densitometry and statistical analyses. Three bands on Western blots were used for density measurements: the thick band above the 66.2-kDa marker, which represents the ␣ chain (63.5 kDa), and the doublet below the 66.2-kDa molecular mass standard, which encompasses the ␤ (56 kDa) and the ␥ (47 kDa) chains of Fg. Density was determined using either ImageJ (version 1.62 [http://rsb.info.nih.gov/nih-image/]) or AlphaVIEW SA (version 3.2.4, build 1021 [ProteinSimple, Santa Clara, CA]). Data obtained using densitometry were analyzed using a single sample t test using the VassarStats website (http://vassarstats.net/). Binding was expressed as the percentage of full-length wild-type (WT) DsrA or absence of competing unlabeled protein, defined as 100% binding. A P value of Ͻ0.05 was considered statistically significant. In order to show specificity of Fg binding at the surface of H. ducreyi bacteria, we used a competition assay with unlabeled and DIG-or FITC-labeled Fg. Addition of increasing amounts of unlabeled Fg prior to incubation of H. ducreyi with DIG-or FITC-Fg reduced ligand binding to the bacterial cell surface (Fig. 1B) (Table 1) , were subjected to ligand blotting probed with DIG-Fg. These mutants were chosen because their targeted mutant proteins are either surface exposed and/or involved in binding proteins of the ECM. DsrA and NcaA are two TAA proteins expressed by H. ducreyi shown to interact with Fn/Vn and collagen, respectively (16, 30) . DltA is a lectin that binds Fn only in ligand blotting but not in whole-cell binding assays (29) . Also included were mutants of the two major OMPs of H. ducreyi, momp and ompA, since the former was shown to be involved in Fn binding by H. ducreyi (16) . Finally, an isogenic mutant lacking the Fg binding protein FgbA (27) was also tested in the Fg binding assay to determine if fgbA binds Fg at the bacterial surface. These mutants were previously characterized for the absence of expression of the targeted protein ( Table 1 ). The ligand blotting method used in this single experiment is different from the Western blot technique described above and used throughout these studies because interactions between DIG-Fg and H. ducreyi proteins occurs in a denatured environment apart from the protein's location in H. ducreyi. Under nonreducing conditions, DIG-Fg bound the TAA DsrA and the H. ducreyi lectin DltA (Fig. 2) . DIG-Fg binding to DltA was lost upon reduction with ␤-mercaptoethanol (data not shown). DIG-Fg did not bind FgbA, as previously reported (27) . These results suggest that both H. ducreyi DltA and DsrA may bind Fg at the bacterial surface.
An H. ducreyi isogenic dsrA mutant binds significantly less Fg at the cell surface than parental H. ducreyi 35000HP (Fig. 3A and data not shown). These results were confirmed by flow cytometry as FITC-Fg binding to the surface of H. ducreyi cells was altered only in the dsrA mutant (Fig. 3B) . Binding by the 35000HP ⌬fgbA isogenic mutant strain in the previously identified Fg binding protein FgbA was not significantly reduced compared to the level of ducreyi strains grown on CAP, including 35000HP and isogenic mutant strains in this background, were subjected to ligand blotting with DIG-Fg under nonreducing conditions. Shown is a representative blot from at least two independent experiments. The location (molecular mass) of the different proteins on the blot is indicated using arrows (18, 27) . The presence of the indicated proteins on the blot was confirmed by Ponceau S staining prior to incubation of the membrane with DIG-Fg. Fig. 3A and B) . The levels of expression of DsrA and DltA were similar in all strains and under all culture conditions tested ( Fig. 3A and data not shown) . The data presented in Fig. 3 show that DsrA appears to be a major determinant of Fg binding at the surface of viable bacteria of H. ducreyi class I strain 35000HP. To determine if Fg binding by DsrA is a general phenomenon among H. ducreyi strains, we examined class I parent and dsrA mutant strain pairs (8) using the unlabeled Fg binding assay, measuring cell-associated Fg by Western blotting. In each case, mutational inactivation of dsrA reduced binding of Fg at the surface of H. ducreyi cells (Fig. 4A) . Moreover, strain HMC21, whose expression of DsrA was lower than that of the other isolates, bound less Fg than the other tested strains. The results of the unlabeled Fg binding assay with multiple dsrA mutants strongly suggest that DsrA is the primary mediator of Fg binding by class I H. ducreyi strains.
35000HP (
Expression of full-length DsrA I or DsrA II renders H. influenzae strain Rd capable of binding Fg. The two classes of H. ducreyi strains express DsrA proteins (encoded by dsrA I or dsrA II ) that are highly similar in their C-terminal translocator domains (86% identity) but different in their passenger domains (18) . We previously showed that both classes of DsrA proteins bind Fn and Vn in the C-terminal regions of their passenger domains (17) . To determine whether class II DsrA proteins are also involved in binding Fg at the surface of viable bacteria, full-length dsrA I or dsrA II was expressed in trans from plasmid pUNCH1260 or pUNCH1296, respectively, in H. influenzae strain Rd, which does not bind Fn, Vn, or Fg (16). Expression of both DsrA I and DsrA II conferred Fg binding to H. influenzae Rd, whether it was grown on CAP or heme plates (Fig. 4B and data not shown) . In contrast, expression of dltA I or an empty vector did not affect Fg binding to H. influenzae Rd. These findings indicated that despite dissimilar primary amino acid sequences in their passenger domains, both DsrA I and DsrA II mediate Fg binding.
A region in the C terminus of the passenger domain of DsrA interacts with Fg.
A panel of DsrA I proteins truncated in their passenger domains was previously used to determine amino acid sequences of DsrA I involved in serum resistance as well as Fn and Vn binding by H. ducreyi (17) . These same truncated DsrA I proteins expressed in the H. ducreyi isogenic dsrA mutant were therefore used to identify the domain of DsrA bound by Fg using the Fg binding assay. The two smallest truncated proteins, DsrA I with a deletion of residues 25 to 170 (DsrA I ⌬25-170) and DsrA I ⌬25-158, bound Fg to the same level as a dsrA mutant expressing an empty vector (Fig. 5) . The next longest construct, DsrA I ⌬25-146, bound Fg to 49% of the level of a strain expressing full-length DsrA I , and DsrA I ⌬25-133 bound 80% of that level (Fig. 5) . Surprisingly, Fg binding by the next-longest truncated DsrA I protein, DsrA I ⌬25-121, was reduced to 50% of the binding of the parent strain (Fig. 5) . Furthermore, larger truncated DsrA I proteins bound Fg at levels similar to the level of the dsrA mutant expressing an empty vector (Fig. 5) . These results were not related to the expression levels of the truncated DsrA I proteins since all but the smallest constructs, DsrA I ⌬25-170 and DsrA I ⌬25-158, appeared to be expressed at levels similar to the level of the full-length DsrA I (Fig. 5) . Reduced surface exposure of truncated DsrA I proteins also did not correlate with the data obtained in the Fg binding assay as all truncated DsrA I proteins, except the two smallest ones, were expressed at levels similar to the level of full-length DsrA I at the bacterial surface (17; also data not shown).
The above-described results could be explained by improper folding of the larger truncated DsrA proteins at the surface of H. ducreyi cells. We postulated that improperly folded DsrA proteins might block the Fg binding site present closer to the bacterial membrane. To test this hypothesis, we removed a 13-amino-acid sequence (LKVLDARISKNKQ) in the C-terminal region of the passenger domain of DsrA (Fig. 6A) . The truncated protein DsrA I ⌬25-133, which contains this sequence, bound the most Fg of all truncated proteins, with 80% of WT levels (Fig. 5) . Removal of these amino acids abrogated binding of H. ducreyi to Fg, as measured using Western blotting (Fig. 6B ) and flow cytometry (Fig. 6C) . In contrast, removal of 12-amino-acid sequences in the translocator domain (MEQNTHNINKLS and NTHNINKLSKEL) did not affect Fg binding (Fig. 6B and C) .
We previously suggested that serum resistance by DsrA might be due to shielding of H. ducreyi surface determinants by the interaction of DsrA with large serum components (17) . To determine whether Fg binding is involved in H. ducreyi serum resistance mediated by DsrA, we measured the survival of the mutants shown in Fig. 6B and C in a bactericidal assay with 50% NHS. Removal of the sequence LKVLD ARISKNKQ did not affect survival of H. ducreyi in NHS (Fig. 6D) . Conversely, removal of one of the sequences in the translocator domain, NTHNINKLSKEL, rendered the H. ducreyi strain expressing this mutation susceptible to the bactericidal activity of NHS (Fig. 6D) . Based on these data, we conclude that Fg binding by H. ducreyi is not involved in serum resistance.
DISCUSSION
In both natural and experimental chancroid, H. ducreyi colocalizes with fibrin (5, 6) . Fibrin is a vital part of the coagulation process, which originates from the transformation of the serum glycoprotein Fg by the action of thrombin (22) . Several strains of H. ducreyi had previously been shown to bind Fg in an agglutination assay (26) . Furthermore, an Fg binding protein had been identified in the prototypical class I strain 35000HP in an assay with denatured H. ducreyi proteins (27) . Based on this information, we sought to determine if viable H. ducreyi bacteria interacted with Fg at the cell surface by incubating soluble Fg with a suspension of H. ducreyi and measuring the cell-associated Fg using Western blotting and flow cytometry. We showed that Fg depleted of Fn, plasminogen, and von Willebrand factor bound the bacterial cell surface in a dose-dependent manner, regardless of the medium used to grow H. ducreyi (Fig. 1A) . This is different from Fn binding by H. ducreyi, which occurs only when bacteria are grown on heme plates, due to the presence of Hb in the growth medium that partially inhibits Fn binding by H. ducreyi (16) . Furthermore, the interaction between viable H. ducreyi bacteria and Fg was specific as unlabeled Fg competed for binding of FITC-and DIG-labeled Fg to the bacterial cell (Fig. 1B) . These findings indicated that the serum glycoprotein Fg interacts specifically at the cell surface of H. ducreyi.
In search of bacterial surface proteins that interacted with Fg, we showed that DIG-Fg bound only two H. ducreyi proteins, DsrA and DltA (Fig. 2) , in ligand blotting against denatured, total cellular proteins from a panel of H. ducreyi OMP mutants. However, ligand blots may not reflect what occurs at the surface of viable H. ducreyi bacteria. For example, DltA was shown to interact with DIG-Fn in ligand blotting, but a dltA mutant was not impaired in its interaction with Fn in a Fn binding assay using viable H. ducreyi cells (16) . We found the same to be true with Fg since only the isogenic dsrA mutant was significantly impaired in its binding to Fg compared to the parent strain in the Fg binding assay with intact H. ducreyi bacteria (Fig. 3) . None of the five other isogenic mutants tested had reduced binding to Fg, including the mutant that lacks the previously identified Fg binding protein FgbA. Furthermore, mutation of the dsrA gene in three other class I strains of H. ducreyi also reduced Fg binding by these strains (Fig. 4A) . These results differ from those for some Gram-positive bacteria like Staphy- (Fig. 4B) . Thus, we conclude that DsrA not only interacts with Fg at the surface of H. ducreyi but also can confer Fg binding to a non-Fg-binding heterologous host.
We previously showed that ECM proteins Fn and Vn bind DsrA in the C-terminal portion of the passenger domain (17) . A short, 53-residue section of the passenger domain of DsrA I , expressed along with the translocator domain (a truncated DsrA protein with residues 25 to 121 removed, where amino acids 1 to 21 encompass the leader peptide and 22 to 170 comprise the passenger domain) (Fig. 6A) , bound 56 and 100%, respectively, the levels of Vn and Fn binding by full-length DsrA I (17) . Truncated DsrA I proteins with larger passenger domains bound Vn and Fn at the same levels as the full-length protein, while constructs with smaller passenger domains bound Vn and Fn at levels similar to those of a dsrA isogenic strain expressing an empty vector (17) . Data presented here show that this does not appear to be the case for Fg binding. Curiously, only the truncated protein with residues 25 to 133 missing (DsrA I ⌬25-133) bound Fg at 80% of the binding levels of full-length DsrA I (Fig. 5) . Interestingly, all other truncated DsrA I proteins bearing a larger passenger domain than DsrA I ⌬25-133 bound less Fg, with most constructs binding Fg at background levels. Based on these data, we speculated that the Fg binding site of DsrA is in the C-terminal portion of the passenger domain, present in proteins DsrA I ⌬25-146 and DsrA I ⌬25-133, encompassing residues LKVLDARISKNKQ (17) . When the truncated DsrA protein is small, this portion of the protein either folds properly and/or is exposed to the surface, enabling its interaction with Fg. However, as the truncations of the passenger domains get smaller and the DsrA constructs get larger, their three-dimensional structures are not native and perhaps are subject to improper folding that hides the Fg binding sites. Only when fulllength DsrA is expressed at the bacterial surface is it capable of adopting a native conformation, and the Fg binding site on DsrA is once again available for interaction with Fg.
We tested this hypothesis by removing the 13-amino-acid sequence LKVLDARISKNKQ, thought to represent the Fg binding domain in full-length DsrA I , and keeping the rest of the protein intact (Fig. 6A) . Removal of this sequence in DsrA significantly reduced binding of Fg by H. ducreyi ( Fig. 6B and C) . Fg binding was not affected when similar-sized sequences were removed in the translocator domain of DsrA (Fig. 6B and C) . These data indicate that LKVLDARISKNKQ is involved in Fg binding by DsrA. We are currently investigating the roles of individual amino acids in this region of DsrA in Fg binding.
The results presented here are consistent with the Fg binding domains identified in Fg binding proteins from Gram-positive bacteria. Three staphylococcal proteins, ClfA, FnpbA, and SdrG, which are critical to pathogenesis of this bacteria, have been shown to interact with Fg through subdomains N of their A regions (31, 32) . Although these subdomains share low amino acid sequence homology, their secondary structures are highly conserved (24) . This suggests that the binding of Fg by ClfA, FnbpA, and SdrG involves a conformational epitope (24) . This may also be the case for DsrA I and DsrA II ; despite their highly different passenger domains, both are capable of mediating Fg binding. However, it is not known at this time if both classes of DsrA proteins share similar secondary structures.
Bauer et al. reported that H. ducreyi expresses an Fg binding protein termed FgbA (27) . The Fg binding phenotype of this lipoprotein was demonstrated using a ligand blot in which DIG-Fg bound to solubilized, denatured whole cells and OMP preparations of class I H. ducreyi strain 35000HP. As shown above, we were unable to reproduce these results. In our hands, DIG-Fg did not bind the 18-kDa FgbA protein in ligand blotting, and an fgbA mutant was not impaired in its interaction with Fg at the surface of H. ducreyi cells in our unlabeled Fg assay (Fig. 3) . The reasons for these conflicting results are still unclear, especially since the source of Fg for all experiments in both reports was the same. Differences in DIG labeling may have denatured Fg, leading to binding of DIG-Fg to FgbA in the results presented by Bauer et al. However, a more likely explanation is that differences in H. ducreyi culture conditions affected protein expression in the two studies. Bauer et al. used mid-log-phase liquid cultures, whereas we used 16-h-old H. ducreyi bacteria from CAP. It is possible that FgbA is only expressed in certain media and/or during certain phases of the growth cycle of H. ducreyi that were not replicated under the conditions used in our studies.
H. ducreyi is highly resistant to the bactericidal activity of NHS (7) . The presence of the DsrA I protein at the surface of the H. ducreyi strain prevents binding of bactericidal IgM at the bacterial cell surface (8) . Because classical inhibitors of the complement system such as Vn and C4BP do not appear to be involved in this process (8) and because there is a correlation between the size of DsrA and the amount of IgM bound at the surface of H. ducreyi (17) , we hypothesized that the mechanism of serum resistance by DsrA involves shielding of target epitopes at the bacterial cell surface. Our results with truncated DsrA I proteins indicate that serum resistance is not associated with Fn or Vn binding to DsrA I because DsrA I ⌬25-133, which retained serum resistance, did not interact with Fn or Vn (17) . However, DsrA I ⌬25-133 is the only truncated protein to interact with Fg at levels similar to the level of full-length DsrA I (Fig. 5) . It was tempting to speculate that a section of DsrA encompassing the peptide LKVLDARISKNKQ is involved in serum resistance as Fg binding and serum resistance appear to coincide in that one region of DsrA. However, our results indicate that larger truncated proteins, which are serum resistant, do not bind Fg. Furthermore, removal of this peptide resulted in loss of Fg binding but retention of serum resistance although these levels were on the edge between serum resistance and susceptibility (53% survival) (Fig.  6D) . We therefore conclude that Fg binding is not involved in H. ducreyi serum resistance mediated by DsrA.
The 236-amino-acid DsrA protein is therefore capable of binding several serum and ECM proteins, along with binding keratinocytes. Although this multifunctionality has rarely been reported for an adhesin in a Gram-negative bacteria (33) , the M protein of group A Streptococcus (GAS) has been ascribed multiple functions, some shared with DsrA, including interaction with many host proteins, like Fg, Fn, IgG, plasminogen, albumin, factor H, collagen IV, and C4BP, and inhibition of phagocytosis (24) . There are several similarities between the H. ducreyi DsrA protein and the M protein of GAS. First, both proteins are relatively small, with a highly conserved C-terminal domain and more variable N-terminal domain (34, 35) . Like many TAAs, M proteins appear as hair-like fibrils at the surface of the cells although this has not been specifically shown for DsrA (34, 35) . Finally, both proteins have a coiled-coil domain that appears to be involved in its multiple functions. M and DsrA proteins also differ. Not all M proteins appear to have the same functions (35) , while both classes of DsrA proteins have so far been shown to mediate Fg, Fn, and Vn binding and resistance to the bactericidal activity of NHS. Furthermore, M proteins contain repeat sequences, whereas DsrA does not appear to have distinct repeated domains (although many TAAs do) (35) . Finally, both proteins are anchored differently to the bacterial surface as they are expressed in bacteria with (H. ducreyi) and without (GAS) an outer membrane.
Using two different methods, we show that the Gram-negative pathogen H. ducreyi interacts with Fg at its bacterial cell surface. This interaction was specific to Fg since addition of unlabeled Fg, but not an irrelevant protein, competed for binding of DIG-and FITC-labeled Fg at the bacterial surface. This binding was mediated through the multifunctional TAA DsrA in four different class I H. ducreyi strains. Furthermore, both classes of DsrA proteins conferred Fg binding to a heterologous host that cannot bind Fg. A 13-amino-acid sequence from DsrA was involved in the interaction of Fg with H. ducreyi. Since Fg binding is critical in the pathogenesis of medically important Gram-positive bacteria, providing definitive proof that intact, viable H. ducreyi bacteria interact with Fg at their surface furthers our understanding of the pathogenesis of chancroid. These data suggest that H. ducreyi interacts with serum Fg present in chancroidal ulcers. These results may also hint that DsrA is the protein that helps H. ducreyi colocalize with fibrin in the base of the ulcer as fibrinogen is the precursor to fibrin. We conclude that DsrA is a multifunctional, surface-exposed TAA involved in binding to several host ligands, including Fg.
